See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
iShares U.S. Healthcare Providers ETF (IHF) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
iShares U.S. Healthcare Providers ETF (IHF) - free report >>
Image: Bigstock
Healthcare ETF (IHF) Hits New 52-Week High
For investors seeking momentum, iShares U.S. Healthcare Providers ETF (IHF - Free Report) is probably on radar now. The fund just hit a 52-week high, which is up roughly 45.6% from its 52-week low price of $139.65/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
IHF in Focus
The fund offers exposure to a basket of healthcare provider companies. The fund charges investors 43 basis points a year in fees and has top holdings Unitedhealth Group, CVS Health Corp and Anthem (see all Healthcare ETFs here).
Why the Move?
Healthcare has been one of the best-performing sectors lately thanks to its non-cyclical nature, which provides a defensive tilt to the fund’s portfolio in a volatile market caused by trade war fear and rising rate worries. Also, a positive regulatory backdrop have helped the fund.
More Gains Ahead?
The fund has a Zacks Rank #2 (Buy) and a positive weighted alpha of 38.60. So, there is definitely still some promise for those who want to ride on this surging ETF a little longer.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>